NEOTON

This brand name is authorized in Lithuania, Poland, Romania.

Active ingredients

The drug NEOTON contains one active pharmaceutical ingredient (API):

1
UNII 020IUV4N33 - PHOSPHOCREATINE
 
Read more about Fosfocreatine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C01EB06 Fosfocreatine C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EB Other cardiac preparations
Discover more medicines within C01EB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
LT Valstybinė vaistų kontrolės tarnyba 1009226, 1010274
PL Rejestru Produktów Leczniczych 100046855
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W66298001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈